Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST

Endonovo Therapeutics Company Description

Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine.

The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.

Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke.

Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Endonovo Therapeutics, Inc.
Country United States
Founded 2008
Industry Biotechnology
Sector Healthcare
Employees 1
CEO Alan Collier

Contact Details

Address:
6320 Canoga Avenue
Woodland Hills, California 91367
United States
Phone 800 489 4774
Website endonovo.com

Stock Details

Ticker Symbol ENDV
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US29272H3003
SIC Code 2836

Key Executives

Name Position
Alan Brian Collier Chairman and Chief Executive Officer
Don Calabria Vice President of Operations
Garry Michael Kann Head of Corporate Development
Ira Weisberg President and Chief Commercial Officer of Medical Division